1h Free Analyst Time
The testosterone replacement therapy market in japan is forecasted to grow by USD 19.41 million during 2025-2030, accelerating at a CAGR of 5.7% during the forecast period. The report on the testosterone replacement therapy market in japan provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by demographic imperative of a super-aging society, advancements in patient-centric delivery mechanisms, destigmatization and proliferation of men health clinics.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The testosterone replacement therapy market in japan is segmented as below:
By Distribution Channel
- Hospitals pharmacies
- Retail pharmacies
- Online pharmacies
By Product
- Injectables
- Topicals
- Oral
- Implants and pellets
- Others
By Material
- Testosterone enanthate
- Testosterone
- Testosterone undecanoate
- Testosterone cypionate
- Others
By End-User
- Hospitals
- Clinics
- Homecare
- Others
By Region
- APAC
- Japan
The report on the testosterone replacement therapy market in japan covers the following areas:
- Testosterone replacement therapy market in japan sizing
- Testosterone replacement therapy market in japan forecast
- Testosterone replacement therapy market in japan industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Distribution Channel
9 Market Segmentation by Product
10 Market Segmentation by Material
11 Market Segmentation by End-user
12 Customer Landscape
13 Drivers, Challenges, and Opportunity
14 Competitive Landscape
15 Competitive Analysis
16 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global testosterone replacement therapy market in japan: AbbVie Inc., ASKA Pharmaceutical Co., Ltd, Bayer AG, Daito Pharmaceutical Co., Ltd, Fuji Pharma Co., Ltd., Kyowa Kirin Co. Ltd., Lupin Ltd., Merck and Co. Inc., Organon and Co., Sun Pharmaceutical Industries, TOWA PHARMACEUTICAL CO.,LTD.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is transition toward non-invasive delivery systems."
According to the report, one of the major drivers for this market is the demographic imperative of a super-aging society.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- ASKA Pharmaceutical Co. Ltd
- Bayer AG
- Daito Pharmaceutical Co. Ltd
- Fuji Pharma Co. Ltd.
- Kyowa Kirin Co. Ltd.
- Lupin Ltd.
- Merck and Co. Inc.
- Organon and Co.
- Sun Pharmaceutical Industries
- TOWA PHARMACEUTICAL CO.,LTD
